Hangzhou Yirui Pharmaceutical Technology Co., Ltd

This is the first study in humans of a new oral medication called YR011. Researchers will test its safety and how the body processes it in 64 healthy volunteers. The study will give people single and multiple doses to check for side effects before testing in patients with specifi…